FT-4101

N/A

Report date: 2024/01/02 20:03:52
NME

Base Information

Drug NameFT-4101
Drug Alias NameFT-4101
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLipid modulators
TargetsLipid
Therapy Area/IndicationsObesityMetabolic Dysfunction-Associated Steatotic Liver Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesForma Therapeutics Holdings Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesForma Therapeutics Holdings IncCelgene Corp
Active IndicationsN/A
Inactive IndicationsObesityMetabolic Dysfunction-Associated Steatotic Liver Disease

Other Information

ATC CodeN/A
Related LinksN/A